Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2026 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$42.82M$42.82Mderived−15.6% vs Q4 2025 Net Income-$4.06M-$4.06MderivedN/M vs Q4 2025 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$13,942,000−8.3% Operating Incomederived-$5,692,000N/M Operating Cash Flowderived-$4,744,000N/M Free Cash Flowderived-$5,464,000N/M Margins · derivedGross margin32.6%+2.6 pt vs Q4 2025
Operating margin-13.3%−1.4 pt vs Q4 2025
Net margin-9.5%+13.5 pt vs Q4 2025
ended Mar 31, 2026 · filed Jun 2, 2026 · 63 d after period end